An interventional study of Maltodextrin and Orange Juice in Gastric Emptying and Pregnancy Vomits, sponsored by Brasilia University Hospital. Completed at 1 site in Brazil. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2018-02-07.
Sponsored by Brasilia University Hospital · Not applicable, Interventional, and Supportive care
This study evaluates the gastric emptying of pregnant woman at term who received one of the three solutions: maltodextrin, orange juice or coffee with milk.
Allocation in maltodextrin, orange juice or coffee with milk will be random using sealed envelopes. Gastric ultrasound will be used for estimating gastric volume by measuring antral area in right lateral decubiti. All solutions will have the same volume and total of calories.
Exclusion Criteria:
Fasted pregnant woman with an empty stomach (assessed by ultrasound) will drink 500ml of maltodextrin 200kcal, no protein or fat, 49,5g of carbohydrate.
Dietary Supplement: Maltodextrin
Fasted pregnant woman with an empty stomach (assessed by ultrasound) will drink 500ml of orange juice, 200kcal, 2,82g of protein, 0,67g of fat, 47,08g of carbohydrate.
Dietary Supplement: Orange Juice
Fasted pregnant woman with an empty stomach (assessed by ultrasound) will drink 500ml of coffee with milk, 200kcal, 10,6g of protein, 10,73g of fat, 14,9g of carbohydrate.
Dietary Supplement: Coffee with milk
Maltodextrin 50g in water 500ml
Orange juice 480ml + 20ml of water
Coffee with milk (330 ml of milk + 220 of water)
Change from Baseline Gastric antral area
Change from Baseline Gastric antral area measured by ultrasound
Time frame: baseline (before drinking allocated solution), 30, 60, 90 and 120 minutes after drinking.
Plan to share: Yes — Will make it available in our website
Supporting information: Study protocol, Sap, Icf, Csr, Analytic code
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brasilia University Hospital